|
|
|
|||||
|
|
||||||
|
Computerized results of Menopause Type® Questionnaire: |
||||||
|
Menopause Type® Six |
See Pages
119-124 |
|||||
|
Menopause Type®
Six has symptoms that reveal decreased estradiol
function, excessive testosterone function,
with adequate progesterone. Health risks associated with Menopause Type® Six may include heart disease. Since estradiol deficiency and
excessive testosterone both play important roles in blood glucose metabolism,
there is also increased risk of insulin resistance and blood sugar disorders.
Risks associated with insulin resistance include increased risk of heart
disease, diabetes and endometrial cancer. |
||||||
|
PROTOCOL: The following protocol provides women with
Menopause Type® 6 information on which nutritional and herbal
formulations can support the normal function of hormone responsive tissues.
Please review the Advanced
Integrative Management of Menopause document for more
detailed information. |
||||||
|
Foundational Interventions: |
||||||
|
Foundational interventions include lifestyle and dietary choices that support optimal hormone function. In addition, a high grade multiple vitamin mineral formulation rich in antioxidants and essential fatty acids rich in docosahexaenoic acid are required for optimal hormone function. |
||||||
|
Ultra Preventive® X V-Cap - A high grade multiple
vitamin and mineral supplement with significant antioxidant support. Vitamins
and minerals are cofactors required
for every biochemical process in the human body, including the production and
proper detoxification of hormones. Oxygen stress contributes to some of the
pathophysiolgical effects of suboptimal menopause. These effects may be prevented
and/or treated by improving the antioxidant defense of perimenopause,
menopause, and postmenopausal women. |
||||||
|
Opti DHA - An essential fatty acid rich in docosahexaenoic acid (DHA) and
eicosapentaenoic acid (EPA), with a high DHA:EPA
ratio. The essential fatty acid DHA
help maintain ideal cell membrane fluidity allowing optimal transport of
molecules across the membrane, which is critical for hormone function, while
EPA helps the body control inflammation. |
||||||
|
Primary Endocrine Formulations : |
||||||
|
Primary
Endocrine Nutraceutical formulations should be used to support the function of
hormone producing glands and hormone responsive tissues. The primary formulations that are
appropriate to manage hormonal imbalances observed in Menopause Type® Six include: |
||||||
|
Estro-Mend™ is a
synergistic formulation of isoflavones, phytoestrogens and other herbs to
naturally support hormonal balance by
supporting the ideal function of estrogen responsive tissues as needed in
Menopause Type® Six. More Information Estro-Mend™ |
||||||
|
Testo-Quench™, a synergistic formulation of phytoantiandrogens designed to restore healthy hormone balance by calming and supporting the ideal
function of testosterone sensitive tissues as needed in Menopause Type®
Six. More Information on Testo-Quench™ |
||||||
|
Please Find a Healthcare Professional in your area to customize these
protocols. |
||||||
|
Secondary
Endocrine Formulations: |
||||||
|
Since decreased thyroid
function can adversely affect the function of other hormones, a nutraceutical formulation to support the function of
the thyroid gland and the liver (which converts T4 to T3)
and also supports the function and response of tissues that respond to
thyroid hormones should be used if there are signs and symptoms of decreased thyroid function. As noted, there may be decreased blood glucose function in
Menopause Type® Six due to the primary hormone imbalances.
Excessive body weight also increases the risk for decreased blood glucose function. A nutraceutical formulation to support healthy blood
glucose function should be used if there are signs and symptoms of decreased blood sugar function |
||||||
|
||||||
|
||||||
|
When to Consider
Hormone Precursors & Bioidentical Hormone Replacement Therapy |
||||||
|
If indicated, a hormone precursor such as Pregnenolone 25 Mg Tab may be used to support
hormone production pathways that create progesterone. It has mild hormone
actions, and does not have the same risks that are associated with Hormone
Replacement Therapies (HRT). Bioidentical Hormone Replacement Therapy (BHRT), while considered more
appropriate than synthetic hormone therapies, does not support the hormone
production pathways, but instead provides “replacement”, which may further
diminish endogenous hormone production. Evaluation
of hormone levels, use of hormone precursors as needed, and as a final course of action, the prescription
of bioidentical hormone therapies should be considered only when
restoration of normal function is not possible. |
||||||
|
Also Review: |
||||||
|
Make the Right Choice |
||||||
|
Work with a Healthcare Professional
in your area: Find a healthcare professional in your area who has shown such
commitment as to take an extensive course of study on menopause type®
management, including nutritional, herbal & natural hormone therapies. Please go to Find a Healthcare Professional . |
||||||
|
How Your
Menopause Type® Was Calculated
(www.YourMenopauseType.com/Questionnaire.html#Calculate) |
||||||
|
|
||||||
|
♦These statements have not been evaluated by the
Food and Drug Administration. |
||||||
|
Review Disclaimer & Legal
(www.YourMenopauseType.com/Disclaimer) |
||||||
YourMenopauseType.com,
Inc.
|
||||||
|
Last
update 03/18/07 |
||||||
|
|
||||||